Melatonin

Half Asleep · 2022 · $14.99 · Action · deal grade A

• Estimated net residual revenue: $5.0k to $7.6k per month
• Opportunity: $8.5k per month at x1.35 dormancy
• Estimated lifetime owners: 240.7k
• 94%% positive across 8161 reviews · 67.5 reviews/month

Why it's flagged

• Developer silent for 20 months
• Studio quiet across its whole catalog
• Last build shipped 15 months ago

Analyst notes (AI-assisted)

Melatonin is a hand-drawn rhythm game where players complete minimalist mini-games synced to an original chill soundtrack.

Melatonin sits in a quiet phase after 14 months, still generating $6.3k/mo residual revenue on 240k lifetime units and a 94% positive rating. The franchise is original IP with no ongoing marketing, no sales velocity in the last year, and a one-title studio, but the strong art direction, accessibility features, and durable player affection suggest the catalog asset could sustain modest publishing support or licensing (soundtrack, merchandise) without major development cost. The opportunity lies not in revival marketing, but in monetization of the existing installed base and IP extension. Most realistic play: licensing.

• Risk: Rhythm game genre is crowded and fickle; player retention data shows steep velocity decline (193 down to 45-73 per month over 24 months) and no sales activity in past 12 months.
• Risk: Control remapping unavailable (noted in reviews), which is a known accessibility friction point and may limit engagement with accessibility-focused audiences.
• Risk: Developer studio is flagged as 'fading' with one title and 20 months since last public communication; successor support or content updates are unlikely without external investment.

This case as Markdown · Estimates carry ±30-50%% error per title.